JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$252,44
Preço · Ago 18, 2026
Fundamentais a partir de Ago 3, 2026
Intervalo 52 Semanas
$118–$265
91% of range
Classificação do Analista
BUY
26 analysts
Preço-Alvo
$281
+11% upside
P/E (TTM)
-29.1
ROE
—
Margem de Lucro Líquido
—
Sobre Jazz Pharmaceuticals plc - Ordinary Shares Visão geral da empresa da Wikipedia
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Ler mais
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
JAZZ Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$252.44
Capitalização de Mercado
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
Receita (TTM)
$4.27B
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$118 – $265
JAZZ Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
Fluxo de caixa livre
—
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
JAZZ
Mediana de Pares
P/E (TTM)
-29.1
530.6
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
JAZZ
Mediana de Pares
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
JAZZ
Mediana de Pares
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
JAZZ
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
4.9%
—
Revenue CAGR 3Y (CAGR Receita 3A)
5.3%
—
Revenue CAGR 5Y (CAGR Receita 5A)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (Lucro Líquido Ano a Ano)
35.0%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
JAZZ
Mediana de Pares
JAZZ Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
26 analistas
- Compra forte 7 26,9%
- Compra 17 65,4%
- Manter 2 7,7%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
20 analistas · 2026-08-15
Mediana
$285.00
Agora
$252.44
Mín
$196.00
Máx
$315.00
Alvo mediano
$285.00
+12,9%
Alvo médio
$281.10
+11,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.06%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $5.71 | $6.30 | -0.59% |
| 31 de Março de 2026 | $6.34 | $4.66 | 1.7% |
| 31 de Dezembro de 2025 | $6.64 | $6.65 | -0.01% |
| 30 de Setembro de 2025 | $8.13 | $6.04 | 2.1% |
| 30 de Junho de 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 de Março de 2025 | $1.68 | $4.75 | -3.1% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
Taxas de Crescimento 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
Demonstração de Resultados 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
Liquidez e Solvência 4
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
Avaliação (TTM) 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| Lucro líquido | $-356M | $560M | $415M | $-224M | $-330M |
| EPS Diluído | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 690 declarantes · $9.8B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 143 (+46 vs trimestre anterior) | 56 (-21 vs trimestre anterior) | 220 (+20 vs trimestre anterior) | 190 (+12 vs trimestre anterior) | +4.4M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| FMR LLC | $846.470.147 | 3.512.762 | 8,60% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731.636.247 | 3.036.213 | 7,43% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $657.763.761 | 2.729.650 | 6,68% | Ações |
| Capital World Investors | $650.043.082 | 2.697.610 | 6,60% | Ações |
| STATE STREET CORP | $481.895.662 | 1.999.816 | 4,89% | Ações |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394.839.917 | 1.638.544 | 4,01% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $390.196.222 | 1.619.274 | 3,96% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $297.928.728 | 1.236.065 | 3,03% | Ações |
| AMERIPRISE FINANCIAL INC | $260.580.996 | 1.081.421 | 2,65% | Ações |
| CITADEL ADVISORS LLC | $242.578.716 | 1.006.676 | 2,46% | Ações |
| Swedbank AB | $233.208.837 | 967.792 | 2,37% | Ações |
| MILLENNIUM MANAGEMENT LLC | $184.072.164 | 763.880 | 1,87% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $165.478.678 | 686.719 | 1,68% | Ações |
| NORGES BANK | $158.279.458 | 656.843 | 1,61% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $135.442.731 | 562.073 | 1,38% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129.891.746 | 539.037 | 1,32% | Ações |
| Allianz Asset Management GmbH | $122.925.785 | 510.129 | 1,25% | Ações |
| GMT Capital Corp | $109.279.895 | 453.500 | 1,11% | Ações |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105.278.106 | 436.893 | 1,07% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103.893.734 | 431.148 | 1,06% | Ações |
| TWO SIGMA INVESTMENTS, LP | $96.439.086 | 400.212 | 0,98% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $95.008.929 | 394.277 | 0,96% | Ações |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89.279.867 | 370.502 | 0,91% | Ações |
| Sofinnova Investments, Inc. | $88.036.221 | 365.341 | 0,89% | Ações |
| Polaris Capital Management, LLC | $79.270.937 | 328.966 | 0,81% | Ações |
| AMERICAN CENTURY COMPANIES INC | $77.695.234 | 322.427 | 0,79% | Ações |
| Bank of New York Mellon Corp | $76.961.481 | 319.382 | 0,78% | Ações |
| GOLDENTREE ASSET MANAGEMENT LP | $70.838.675 | 294.435 | 0,72% | Ações |
| Qube Research & Technologies Ltd | $70.056.003 | 290.725 | 0,71% | Ações |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66.815.854 | 277.279 | 0,68% | Ações |
| Quantinno Capital Management LP | $65.906.960 | 273.506 | 0,67% | Ações |
| Boston Trust Walden Corp | $64.110.068 | 266.050 | 0,65% | Ações |
| BANK OF AMERICA CORP /DE/ | $60.589.497 | 251.440 | 0,62% | Ações |
| Tri Locum Partners LP | $53.427.868 | 221.720 | 0,54% | Ações |
| Iron Triangle Partners LP | $49.668.900 | 292.170 | 0,50% | Ações |
| ARGENT CAPITAL MANAGEMENT LLC | $48.211.350 | 200.072 | 0,49% | Ações |
| GOLDMAN SACHS GROUP INC | $45.527.185 | 188.933 | 0,46% | Ações |
| PERCEPTIVE ADVISORS LLC | $40.964.900 | 170.000 | 0,42% | Ações |
| RAYMOND JAMES FINANCIAL INC | $39.434.259 | 163.648 | 0,40% | Ações |
| RHUMBLINE ADVISERS | $39.282.382 | 163.018 | 0,40% | Ações |
| Holocene Advisors, LP | $38.794.001 | 160.991 | 0,39% | Ações |
| Saturn V Capital Management LP | $38.781.230 | 160.938 | 0,39% | Ações |
| PFM Health Sciences, LP | $38.740.265 | 160.768 | 0,39% | Ações |
| Retirement Systems of Alabama | $38.473.993 | 159.663 | 0,39% | Ações |
| Woodline Partners LP | $36.165.501 | 150.083 | 0,37% | Ações |
| LOOMIS SAYLES & CO L P | $35.355.338 | 146.721 | 0,36% | Ações |
| Pictet Asset Management Holding SA | $35.115.175 | 147.599 | 0,36% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $34.163.762 | 141.776 | 0,35% | Ações |
| STIFEL FINANCIAL CORP | $33.583.066 | 139.365 | 0,34% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $33.026.625 | 137.057 | 0,34% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32.383.478 | 134.388 | 0,33% | Ações |
| California Public Employees Retirement System | $30.759.098 | 127.647 | 0,31% | Ações |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30.249.134 | 160.006 | 0,31% | Ações |
| Robeco Institutional Asset Management B.V. | $28.340.967 | 117.612 | 0,29% | Ações |
| Gotham Asset Management, LLC | $26.992.014 | 112.014 | 0,27% | Ações |
| Aristotle Capital Management, LLC | $26.915.626 | 111.697 | 0,27% | Ações |
| Swiss National Bank | $26.771.767 | 111.100 | 0,27% | Ações |
| STOREBRAND ASSET MANAGEMENT AS | $26.309.828 | 109.183 | 0,27% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $25.928.372 | 107.600 | 0,26% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $25.286.187 | 104.935 | 0,26% | Ações |
| BlackRock, Inc. | $23.889.284 | 99.138 | 0,24% | Ações |
| Perpetual Ltd | $23.733.376 | 98.491 | 0,24% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $23.658.917 | 98.182 | 0,24% | Ações |
| MORGAN STANLEY | $23.519.795 | 97.604 | 0,24% | Ações |
| Man Group plc | $23.299.389 | 96.690 | 0,24% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.868.053 | 94.900 | 0,23% | Opção de venda |
| ENVESTNET ASSET MANAGEMENT INC | $22.061.835 | 91.554 | 0,22% | Ações |
| Rhenman & Partners Asset Management AB | $21.070.417 | 87.440 | 0,21% | Ações |
| Aberdeen Group plc | $20.146.538 | 83.606 | 0,20% | Ações |
| Amundi | $19.114.464 | 79.323 | 0,19% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.916.145 | 78.500 | 0,19% | Opção de compra |
| Schonfeld Strategic Advisors LLC | $18.620.232 | 77.272 | 0,19% | Ações |
| FIRST TRUST ADVISORS LP | $18.149.860 | 75.320 | 0,18% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17.765.513 | 73.725 | 0,18% | Ações |
| LAZARD ASSET MANAGEMENT LLC | $16.768.620 | 69.588 | 0,17% | Ações |
| Longaeva Partners L.P. | $16.576.808 | 68.792 | 0,17% | Ações |
| Simplify Asset Management Inc. | $16.520.903 | 68.560 | 0,17% | Ações |
| ALLIANCEBERNSTEIN L.P. | $16.497.448 | 87.265 | 0,17% | Ações |
| Distillate Capital Partners LLC | $16.167.159 | 67.092 | 0,16% | Ações |
| SEB Asset Management AB | $15.890.255 | 65.943 | 0,16% | Ações |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15.380.484 | 64.700 | 0,16% | Ações |
| SEI INVESTMENTS CO | $14.931.224 | 61.963 | 0,15% | Ações |
| Illinois Municipal Retirement Fund | $14.911.947 | 61.883 | 0,15% | Ações |
| Tweedy, Browne Co LLC | $14.494.105 | 60.149 | 0,15% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $14.335.788 | 59.492 | 0,15% | Ações |
| DeepCurrents Investment Group LLC | $14.132.168 | 58.647 | 0,14% | Ações |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13.348.774 | 55.396 | 0,14% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $12.952.138 | 53.750 | 0,13% | Ações |
| ExodusPoint Capital Management, LP | $12.819.845 | 53.201 | 0,13% | Ações |
| Squarepoint Ops LLC | $12.807.074 | 53.148 | 0,13% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.034.356 | 63.657 | 0,12% | Ações |
| ALGERT GLOBAL LLC | $11.749.697 | 48.760 | 0,12% | Ações |
| CASTLEARK MANAGEMENT LLC | $11.306.312 | 46.920 | 0,11% | Ações |
| CITADEL ADVISORS LLC | $11.253.299 | 46.700 | 0,11% | Opção de compra |
| RENAISSANCE GROUP LLC | $11.221.601 | 46.568 | 0,11% | Ações |
| Nuveen, LLC | $11.184.623 | 46.415 | 0,11% | Ações |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10.859.795 | 45.067 | 0,11% | Ações |
| Foundry Partners, LLC | $10.730.160 | 86.429 | 0,11% | Ações |
| Legal & General Group Plc | $10.402.916 | 43.171 | 0,11% | Ações |
| DEAN INVESTMENT ASSOCIATES, LLC | $10.273.274 | 42.633 | 0,10% | Ações |
Executivos da empresa 50 insiders · 4 diretores · 4 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 de Junho de 2026 F | 147.361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 de Junho de 2026 F | 56.431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 de Junho de 2026 F | 48.871 | 0 | 2 | $-560.664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 de Junho de 2026 F | 85.107 | 0 | 0 | $0 |
| Bryan C Cressey | Conselheiro | 9 de Março de 2012 S | 27.631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | Conselheiro | 10 de Março de 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | Conselheiro | 15 de Agosto de 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | Conselheiro | 15 de Agosto de 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 5 de Agosto de 2026 A | 8.307 | 0 | 0 | $0 |
| Samantha Pearce | — | 5 de Agosto de 2026 F | 47.131 | 0 | 1 | $-1.625.977 |
| Mark Douglas Smith | — | 5 de Agosto de 2026 A | 11.285 | 0 | 1 | $-266.746 |
| Jennifer E. Cook | — | 5 de Agosto de 2026 A | 12.442 | 0 | 0 | $0 |
| Laura Hamill | — | 5 de Agosto de 2026 A | 8.538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 5 de Agosto de 2026 A | 20.054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 5 de Agosto de 2026 A | 1.184.633 | 0 | 0 | $0 |
| Rick E Winningham | — | 5 de Agosto de 2026 A | 11.172 | 0 | 2 | $-1.656.873 |
| Patrick G. Enright | — | 5 de Agosto de 2026 A | 22.984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 5 de Agosto de 2026 A | 362.287 | 0 | 20 | $-25.646.326 |
| Ted W Love | — | 5 de Agosto de 2026 A | 3.132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 5 de Agosto de 2026 A | 8.629 | 0 | 1 | $-655.680 |
| Kenneth W O'Keefe | — | 2 de Dezembro de 2025 F | 25.811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 3 de Janeiro de 2019 F | 16.512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 de Dezembro de 2018 M | 41.184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 de Novembro de 2018 S | 32.068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 de Novembro de 2018 S | 24.972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 de Agosto de 2018 S | 17.458 | 0 | 0 | $0 |
| Elmar Schnee | — | 9 de Agosto de 2018 A | 6.094 | 0 | 0 | $0 |
| Peter Gray | — | 9 de Agosto de 2018 A | 8.182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 9 de Agosto de 2018 A | 7.654 | 0 | 0 | $0 |
| Paul L Berns | — | 9 de Agosto de 2018 A | 6.772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 de Maio de 2018 S | 15.757 | 0 | 0 | $0 |
| Karen L. Smith | — | 5 de Março de 2018 F | 28.474 | 0 | 0 | $0 |
| Iain Mcgill | — | 5 de Março de 2018 F | 22.048 | 0 | 0 | $0 |
| Russell J. Cox | — | 6 de Março de 2017 F | 52.795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 5 de Março de 2015 F | 38.484 | 0 | 0 | $0 |
| Fintan Keegan | — | 8 de Julho de 2014 M | 31.750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 5 de Março de 2014 F | 133.387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 de Agosto de 2013 S | 17.315 | 0 | 0 | $0 |
| Carol A Gamble | — | 9 de Março de 2012 S | 32.213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 9 de Março de 2012 S | 54.355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 de Janeiro de 2012 M | 38.347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 de Janeiro de 2012 M | 13.885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 de Agosto de 2011 M | 4.151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 de Agosto de 2011 M | 14.574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 de Maio de 2011 J | 48.544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 de Novembro de 2010 J | 14.424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 de Novembro de 2010 J | 156.898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 de Agosto de 2010 A | 21.366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 de Janeiro de 2009 A | 358.868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 de Novembro de 2008 J | 58.948 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 declarações | 20 de Junho de 2014 | — | Declaração inicial | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 declarações | 12 de Março de 2013 | — | Declaração inicial | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 declarações | 14 de Março de 2012 | — | Declaração inicial | — | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 declarações | 30 de Setembro de 2011 | — | Declaração inicial | — | SEC |
| Azur Pharma Limited | 28 de Setembro de 2011 | — | Declaração inicial | — | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 de Abril de 2005 | — | Declaração inicial | M&A / venda | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 72 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHE · iShares Trust | 3,55% | 224.123 SH | 8 de Agosto de 2026 | Diário |
| PJP · Invesco Exchange-Traded Fund Trust | 2,75% | 54.246 SH | 8 de Agosto de 2026 | Diário |
| PTH · Invesco Exchange-Traded Fund Trust | 1,88% | 18.101 SH | 8 de Agosto de 2026 | Diário |
| PILL · Direxion Shares ETF Trust | 1,47% | 931 NS | 30 de Abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,10% | 3.412 SH | 8 de Agosto de 2026 | Diário |
| RFG · Invesco Exchange-Traded Fund Trust | 1,01% | 14.167 SH | 8 de Agosto de 2026 | Diário |
| IJK · iShares Trust | 0,86% | 367.117 SH | 8 de Agosto de 2026 | Diário |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,79% | 61.910 SH | 8 de Agosto de 2026 | Diário |
| PDP · Invesco Exchange-Traded Fund Trust | 0,64% | 37.430 SH | 8 de Agosto de 2026 | Diário |
| XJH · iShares Trust | 0,51% | 8.479 SH | 8 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | 0,50% | 13.756 SH | 8 de Agosto de 2026 | Diário |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,50% | 14.803 NS | 30 de Abril de 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,49% | 12.809 NS | 31 de Maio de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,48% | 8.322 SH | 8 de Agosto de 2026 | Diário |
| IJH · iShares Trust | 0,44% | 2.164.793 SH | 8 de Agosto de 2026 | Diário |
| SMMV · iShares Trust | 0,41% | 4.673 SH | 8 de Agosto de 2026 | Diário |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,41% | 101.353 SH | 8 de Agosto de 2026 | Diário |
| VFVA · VANGUARD WELLINGTON FUND | 0,32% | 11.363 SH | 8 de Agosto de 2026 | Diário |
| VBR · VANGUARD INDEX FUNDS | 0,31% | 867.777 SH | 8 de Agosto de 2026 | Diário |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,28% | 154.718 NS | 31 de Maio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,28% | 8.083 SH | 8 de Agosto de 2026 | Diário |
| IYH · iShares Trust | 0,25% | 35.721 SH | 8 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | 0,25% | 2.794 SH | 8 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,25% | 169.973 NS | 30 de Abril de 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1.006 NS | 30 de Abril de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,24% | 19.561 SH | 8 de Agosto de 2026 | Diário |
| NUSC · Nushares ETF Trust | 0,23% | 14.796 NS | 30 de Abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,23% | 25.562 SH | 8 de Agosto de 2026 | Diário |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,20% | 3.508 NS | 31 de Maio de 2026 | N-PORT |
| SMMD · iShares Trust | 0,20% | 29.882 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,20% | 166.548 SH | 8 de Agosto de 2026 | Diário |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,20% | 10.307 SH | 8 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,17% | 719.903 SH | 8 de Agosto de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,17% | 1.366.973 SH | 8 de Agosto de 2026 | Diário |
| DFAT · Dimensional ETF Trust | 0,17% | 113.983 NS | 30 de Abril de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,16% | 59.597 NS | 30 de Abril de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,15% | 1.679 NS | 31 de Maio de 2026 | N-PORT |
| IWS · iShares Trust | 0,15% | 89.654 SH | 8 de Agosto de 2026 | Diário |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,14% | 59 NS | 31 de Maio de 2026 | N-PORT |
| WSML · iShares Trust | 0,13% | 3.473 SH | 8 de Agosto de 2026 | Diário |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,13% | 2.492 NS | 31 de Maio de 2026 | N-PORT |
| IWR · iShares Trust | 0,11% | 243.081 SH | 8 de Agosto de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3.276 SH | 8 de Agosto de 2026 | Diário |
| XT · iShares Trust | 0,09% | 13.696 SH | 8 de Agosto de 2026 | Diário |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,08% | 4.239 NS | 31 de Maio de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,08% | 42.911 NS | 31 de Maio de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,07% | 2.294 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 147.813 NS | 30 de Abril de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 45.962 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 7.081 NS | 30 de Abril de 2026 | N-PORT |